Jonathan S. Edwards is Director at Phathom Pharmaceuticals, Inc. (PHAT). They have made 1 open-market trade across 1 company since 2019, most recently 2019-10-29.
CIK 0001791944
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $20.0M since 2019, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PHAT | 23,558 | $163K |
Shares reported on the most recent Form 4, priced at the 2019-10-30 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PHAT | BUY | 2019-10-29 | 2019-10-30 | $19.00 | $20.0M | +15.2% | +10.6% | +64.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.